Last $5.09 USD
Change Today +0.09 / 1.80%
Volume 25.7K
CO On Other Exchanges
New York
As of 8:04 PM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

china cord blood corp (CO) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/24/14 - $5.70
52 Week Low
11/15/13 - $3.70
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CHINA CORD BLOOD CORP (CO)

china cord blood corp (CO) Related Businessweek News

No Related Businessweek News Found

china cord blood corp (CO) Details

China Cord Blood Corporation, together with its subsidiaries, primarily provides umbilical cord blood storage and ancillary services in the People’s Republic of China. The company provides cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as offers matching services. As of March 31, 2014, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. China Cord Blood Corporation is based in Central, Hong Kong.

944 Employees
Last Reported Date: 07/31/14

china cord blood corp (CO) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: $701.0K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $701.0K
Chief Executive Officer of Guangdong Division...
Total Annual Compensation: $435.2K
Chief Executive Officer of Beijing Division
Total Annual Compensation: $244.3K
Chief Technology Officer
Total Annual Compensation: $177.3K
Compensation as of Fiscal Year 2014.

china cord blood corp (CO) Key Developments

China Cord Blood Corporation Reports Preliminary Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2014

China Cord Blood Corporation reported preliminary unaudited consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported revenues of RMB 153,331,000 compared to RMB 128,721,000 for the same period a year ago. Operating income was RMB 60,167,000 compared to RMB 45,880,000 for the same period a year ago. Income before income tax was RMB 41,531,000 compared to RMB 44,432,000 for the same period a year ago. Net income attributable to company shareholders was RMB 29,736,000 or RMB 0.37 per basic and diluted share compared to RMB 32,906,000 or RMB 0.40 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was RMB 124,643,000.

Golden Meditech Mulls Acquisitions

Golden Meditech Holdings Limited (SEHK:801) entered into an agreement to sell its 7% senior convertible note due 2017 in an aggregate principal amount of $50 million issued on October 3, 2012 by China Cord Blood Corporation (NYSE:CO). The proceeds will be used to fund its potential acquisitions or expansion of its existing healthcare related businesses in mainland China.

China Cord Blood Corporation to Report Q1, 2015 Results on Aug 28, 2014

China Cord Blood Corporation announced that they will report Q1, 2015 results at 5:00 PM, China Standard Time on Aug 28, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CO:US $5.09 USD +0.09

CO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CO.
View Industry Companies

Industry Analysis


Industry Average

Valuation CO Industry Range
Price/Earnings 19.8x
Price/Sales 4.2x
Price/Book 1.5x
Price/Cash Flow 17.6x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA CORD BLOOD CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at